Ignite Creation Date:
2025-12-25 @ 3:04 AM
Ignite Modification Date:
2025-12-26 @ 1:43 AM
Study NCT ID:
NCT00238433
Status:
COMPLETED
Last Update Posted:
2017-09-27
First Post:
2005-10-12
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma
Sponsor:
OHSU Knight Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-03
Start Date Type:
None
Primary Completion Date:
2015-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-12
Completion Date Type:
ACTUAL
First Submit Date:
2005-10-12
First Submit QC Date:
None
Study First Post Date:
2005-10-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-03-31
Results First Submit QC Date:
None
Results First Post Date:
2017-05-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2016-12-29
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2017-09-25
Last Update Post Date:
2017-09-27
Last Update Post Date Type:
ACTUAL